Newsroom Stories

Well-being Wednesdays, a Student Affairs initiative, offer the WashU community an opportunity to learn about wellness-related programs, buy fresh produce, enjoy a free cup of coffee and take a moment to relax.

Three WashU investigators have been recognized with prestigious awards through the National Institutes of Health (NIH) Director’s High-Risk, High-Reward Research program, which supports unconventional approaches to major challenges in biomedical and behavioral research.

What is artificial intelligence good at? What is it not good at? How might it reshape the employment landscape? Last spring, WashU’s Ian Bogost interviewed Andrew “Boz” Bosworth, chief technology officer at Meta, and others for Bogost’s class “How AI Will Change Your Career.”

New research from WashU Medicine identified a key enzyme that enables rotavirus to infect cells. Disabling this enzyme prevented infection, suggesting new treatments against rotavirus and other pathogens that rely on similar mechanisms.

WashU’s Prevention Research Center delivered its Evidence-Based Public Health training in Puerto Rico, strengthening local health workforce capacity to tackle chronic disease and limited resources.

Researchers at Washington University in St. Louis will provide cameras for the world’s largest high-energy gamma-ray observatory with a nearly $4 million federal grant.

Led by members of the women’s tennis team, the WashU chapter of Second Serves hosts tennis clinics for the local community and provides donated rackets and covers, shoes and tennis bags for children.

WashU Medicine researchers found that immune cells that dispose of the body’s cellular debris can protect insulin-producing cells and prevent Type 1 diabetes in mice.

Funding from the National Science Foundation will enable researchers across many disciplines at Washington University in St. Louis to advance ongoing research into the damaging health effects of repeated flooding in Metro East communities.

Neuroscientists, clinicians and engineers at Washington University in St. Louis seek to develop personalized medicine strategies for refractory depression that would tailor drug dosage based on a patient’s age, genetics, health conditions, brain dynamics and neural circuits.